This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehta, R. H. Search for Related Content PubMed PubMed Citation Articles by Mehta, R. H.

Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention

Incidence, predictors, and outcomes

Rajendra H. Mehta, MD, MS^*,*, Kishore J. Harjai, MD, Lorelei Grines, PhD, Gregg W. Stone, MD, Judy Boura, MS, David Cox, MD, William O'Neill, MD, Cindy L. Grines, MD Primary Angioplasty in Myocardial Infarction (PAMI) Investigators

^* University of Michigan, Ann Arbor, Michigan, USA
William Beaumont Hospital, Royal Oak, Michigan, USA
Lenox Hill Hospital, New York, New York, USA
Mid Carolina Cardiology, Charlotte, North Carolina, USA

View larger version (93K): [in a new window]   Figure 1 Electrocardiographic tracings of ventricular fibrillation (A) and ventricular tachycardia (B) during primary percutaneous coronary intervention.

View larger version (15K): [in a new window]   Figure 2 Time from symptom onset to emergency room (ER) arrival and frequency of ventricular tachycardia/ventricular fibrillation (VT/VF). The Cochran-Mantel-Haenszel statistic = 9.2, df 1, p < 0.0024 for trend.

View larger version (15K): [in a new window]   Figure 3 Increasing number of risk factors for ventricular tachycardia/ventricular fibrillation (VT/VF) (as shown in Table 4) and the incidence of these arrhythmias. The Cochran-Mantel-Haenszel statistic = 50.7, df 1, p < 0.0001 for trend.